Cerebral metabolism in a case of multiple sclerosis with acute mental disorder

M Blinkenberg1, K Rune, A Jønsson

  • 1Department of Neurology, National Hospital (Rigshospitalet), Copenhagen, Denmark.

Insights

This study details a rare case of acute mental disorder in early Multiple Sclerosis (MS). Positron emission tomography revealed reduced glucose metabolism in the brain, correlating with cognitive dysfunction and frontal lobe syndrome in MS patients.

Area of Science:

  • Neurology
  • Neuroscience
  • Psychiatry

Background:

  • Acute mental disorder is a rare manifestation in early Multiple Sclerosis (MS).
  • Limited understanding exists regarding the structural and metabolic brain changes associated with these acute mental changes in MS.
  • Early diagnosis and characterization of neurological and psychiatric symptoms in MS are crucial for effective management.

Observation:

  • A patient with early Multiple Sclerosis (MS) presented with subtle motor and sensory deficits.
  • Over nine months, the patient developed severe behavioral and mental changes during the initial disease course.
  • The patient underwent comprehensive neuropsychological testing, Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) for metabolic assessment.

Findings:

  • Positron emission tomography (PET) revealed significantly reduced cerebral metabolic rate of glucose (CMRglc) bilaterally in the frontal and temporal cortex, putamen, thalamus, and hippocampus.
  • MRI demonstrated progression of MS lesions in the frontal lobes coinciding with the onset of mental symptoms.
  • Neuropsychological evaluation indicated widespread cognitive dysfunction and a pronounced frontal lobe syndrome.

Implications:

  • This case highlights the potential for remote metabolic effects of MS lesions on subcortical neural connections.
  • The findings suggest that structural changes in MS can lead to significant cognitive and behavioral disturbances.
  • Understanding these metabolic changes is vital for diagnosing and managing psychiatric and cognitive dysfunction in Multiple Sclerosis.